Company intelligence / Profile preview

AQPHA Medical

Utrecht, Utrecht, Netherlandsaqphamedical.com ↗

Ownership: Private
Development stage: Other

Overview

AQPHA Medical is pioneering regenerative particle fillers for aesthetic medicine. Their lead product, MONA, uses PTMC microspheres to provide controlled degradation and optimal tissue integration with minimized inflammation. MONA is currently under clinical investigation to ensure safety and efficacy.

Therapeutic areas: Dermatology
Modalities: Device (specifically, regenerative dermal filler using PTMC microspheres)
Industry: Implantable Medical Devices

Partnerships

None publicly disclosed

Beyond the preview

Go deeper on AQPHA Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AQPHA Medical.

Explore the full profile